Home » Topics » Regulatory

Regulatory
RSS

New cisapride formulation introduced in U.K.

March 9, 1998

Once-a-day Cozaar introduced in Canada

March 9, 1998

New indication for Mobic cleared by U.K. authorities

March 6, 1998

FDA approves expanded indications for Dynabac

March 6, 1998

FDA okays labeling change for Pulmozyme

March 3, 1998

Once-daily formulation of paroxetine submitted for FDA review

March 3, 1998

Alferon N Injection for HIV-infected patients makes progress

Feb. 26, 1998

Floxin Otic launched in U.S.

Feb. 24, 1998

Beneficial effects of lisinopril on progression of retinopathy in IDDM

Feb. 20, 1998

Rebif launched in Canada: first drug to delay disease progression in remitting-relapsing MS

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...